Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Mar 17, 2014 (13 years ago)

Papaverine 60 mg

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Incorrect Expiration Date; Expiration date is earlier than listed on vial.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Papaverine 60 mg, Phentolamine 4 mg, and Atropine 0.3 mg Solution, 10 mL Vial, Rx Only. Not for Resale. John Hollis Pharmacy, 110 20th Avenue N, Nashville, TN 37203.

Drug: Papaverine

Recalling firm
John W Hollis Inc
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1258-2014 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Papaverine recalls

See all
Class I · High risk

Papaverine HCl Injection

Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde

Ongoing Particulate / foreign matter American Regent, Inc. NDC 0517-4002-01 D-0800-2026

Other recalls by John W Hollis Inc

All 2014 recalls
Class II · Moderate risk

Pyridoxine HCL

Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.

Terminated Sterility / contamination John W Hollis Inc D-1405-2014
Class II · Moderate risk

Lipotropic Gold

Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.

Terminated Sterility / contamination John W Hollis Inc D-1404-2014
Class II · Moderate risk

Papaverine HCl 30 mg

Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.

Terminated Sterility / contamination John W Hollis Inc D-1403-2014